home All News open_in_new Full Article

US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership

US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership  Reuters


today 8 d. ago attach_file Other

8 d. ago Bio Japan 2025: Investors riff about what they look for in Japan
attach_file Other
8 d. ago US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership
attach_file Other
1 week ago Korean bio firms tap Bio Japan 2025 to bolster global opportunities
attach_file Other
2 w. ago Bio Japan 2025: Nobel Prizes invigorate Japan’s bio industry
attach_file Other
3 w. ago Japan: Fujitsu Frontiers dominate Oriental Bio Silver Star in XLeague victory
attach_file Other
3 w. ago Nuvation Bio Surges on Japanese Approval of Ibtrozi for Lung Cancer
attach_file Other
3 w. ago Nuvation Bio Soars As Japan Approves Ibtrozi for Advanced Lung Cancer
attach_file Other
last month Nuvation Bio stock gains as Japan approves IBTROZI for lung cancer
attach_file Other


ID: 2937358154
Add Watch Country

arrow_drop_down